Young Joo Park

Randomized Phase II Study of Multiple Dose Levels of CCI-779, a Novel Mammalian Target of Rapamycin Kinase Inhibitor, in Patients With Advanced Refractory Renal Cell Carcinoma

Michael B. Atkins, Manuel Hidalgo, Walter M. Stadler et al. · Journal of Clinical Oncology · 2004 · 943 citations · Full text

Urology, Advanced Rcc Patients, Genitourinary Cancer +15

Sarcopenic Obesity: Prevalence and Association With Metabolic Syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA)

Soo Lim, Jung Hee Kim, Ji Won Yoon et al. · Diabetes Care · 2010 · 588 citations · Full text

Comprehensive Analysis of the Transcriptional and Mutational Landscape of Follicular and Papillary Thyroid Cancers

Seong‐Keun Yoo, Seungbok Lee, Su‐jin Kim et al. · PLoS Genetics · 2016 · 340 citations · Full text

Engineering, Genetics, Pathology +21

Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer

Seong‐Keun Yoo, Young Shin Song, Eun Kyung Lee et al. · Nature Communications · 2019 · 254 citations · Full text

The Mitogenic and Antiapoptotic Actions of Ghrelin in 3T3-L1 Adipocytes

Min‐Seon Kim, Cho Ya Yoon, Pil Geum Jang et al. · Molecular Endocrinology · 2004 · 230 citations · Full text

Mitophagy, Cellular Physiology, Insulin Signaling +24